Skip to content
ReportWire

Breaking News & Top Current Stories – Latest US News and News from Around the World

Tag: life sciences

How China’s Chokehold on Drugs, Chips and More Threatens the U.S.

November 4, 2025November 4, 2025 · World News

BEIJING—China has demonstrated it can weaponize its control over global supply chains by constricting the flow of critical rare-earth minerals. President Trump went to the negotiating table when…

Read more How China’s Chokehold on Drugs, Chips and More Threatens the U.S.

Trump Says Xi Will Help Fight Fentanyl. Will China Follow Through?

November 3, 2025November 3, 2025 · World News

For years, the U.S. and China have been locked in a pattern on the deadly issue of fentanyl. The White House pressures Beijing to stop Chinese companies from…

Read more Trump Says Xi Will Help Fight Fentanyl. Will China Follow Through?

The Long Road to a U.S.-China Trade Pact

October 30, 2025November 1, 2025 · World News

In March, Sen. Steve Daines traveled to Beijing with a group of American chief executives in hopes of calming a tense trade relationship between the world’s two largest…

Read more The Long Road to a U.S.-China Trade Pact

Trump Turns Up Heat on Latin America

October 19, 2025October 19, 2025 · World News

President Trump’s vow to intervene against drug smugglers in Colombia widened a U.S. counternarcotics campaign in Latin America that began with military strikes on oceangoing boats but is…

Read more Trump Turns Up Heat on Latin America

Trump Says U.S. Is Cutting Aid to Colombia Over Drugs

October 19, 2025October 19, 2025 · World News

President Trump said the U.S. would stop aid payments to Colombia, for decades a close U.S. ally, because of the country’s drug production. Trump, in a social-media post…

Read more Trump Says U.S. Is Cutting Aid to Colombia Over Drugs

Dayforce, Scholar Rock, and More Stocks See Action From Activist Investors

October 17, 2025October 18, 2025 · Business

Dayforce, Scholar Rock, and More Stocks See Action From Activist Investors Source link

Read more Dayforce, Scholar Rock, and More Stocks See Action From Activist Investors

Life sciences advocates, economic development agencies launch centralized hub | Long Island Business News

October 3, 2025October 4, 2025 · Business

New York Bio Connect, a new health and life sciences hub, has officially launched to serve as a central resource for New York’s life science community. Designed to…

Read more Life sciences advocates, economic development agencies launch centralized hub | Long Island Business News

Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model Platform

July 29, 2025August 26, 2025 · Education

Sia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs).…

Read more Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model Platform
MCC’s biotechnology program receives Pathmaker Validation from Mass Life Sciences Center

MCC’s biotechnology program receives Pathmaker Validation from Mass Life Sciences Center

September 28, 2024September 28, 2024 · Boston, Massachusetts Local News

On Aug. 13, Middlesex Community College’s biotechnology program received a Pathmaker Validation from the Mass Life Sciences Center. Representatives from MLSC joined Middlesex President Phil Sisson, Provost Arlene…

Read more MCC’s biotechnology program receives Pathmaker Validation from Mass Life Sciences Center
GSK PLC 4Q Pre-items, Pretax Pft GBP1.56B

GSK PLC 4Q Pre-items, Pretax Pft GBP1.56B

January 30, 2024January 31, 2024 · Breaking News

Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections & Amplifications This headline was corrected…

Read more GSK PLC 4Q Pre-items, Pretax Pft GBP1.56B
GSK PLC 4Q Pre-items, Pretax Pft GBP1.56B

Roche's Cancer Injection Tecentriq SC Gets European Commission Approval

January 15, 2024January 15, 2024 · Breaking News

By Andrea Figueras Roche said that the European Commission approved Tecentriq SC, a cancer immunotherapy subcutaneous injection for multiple cancer types. The Swiss pharmaceutical company said Tuesday that…

Read more Roche's Cancer Injection Tecentriq SC Gets European Commission Approval
Medical Properties Trust Stock Is Crashing

Medical Properties Trust Stock Is Crashing

January 5, 2024January 5, 2024 · Business

Shares of Medical Properties Trust plummeted after the real estate investment trust said it is ramping up efforts to recover uncollected rent and outstanding loans from its largest…

Read more Medical Properties Trust Stock Is Crashing
The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

January 2, 2024January 2, 2024 · Breaking News

The Russell 2000 Index soared 12% in December, which might reflect investors’ exuberance about the state of the U.S. economy — it appears the Federal Reserve has won…

Read more The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks
These 20 stocks soared the most in 2023

These 20 stocks soared the most in 2023

December 30, 2023December 30, 2023 · Breaking News

(Updated with Friday’s closing prices.) The 2023 rally for stocks in the U.S. accelerated as more investors bought the idea that the Federal Reserve succeeded in its effort…

Read more These 20 stocks soared the most in 2023
Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers

Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers

December 27, 2023December 27, 2023 · Business

Updated Dec 27, 2023, 7:34 am EST / Original Dec 27, 2023, 4:26 am EST Stock futures traded slightly lower Wednesday after the S&P 500 finished higher Tuesday and…

Read more Intel, Tesla, Apple, Iovance, NetEase, Coherus BioSciences, and More Stock Market Movers
Bristol Myers to Acquire RayzeBio in Deal Valued at .1 Billion

Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion

December 26, 2023December 26, 2023 · Business

Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options Source link

Read more Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion
Bluebird Bio Stock Is in Free Fall

Bluebird Bio Stock Is in Free Fall

December 20, 2023December 20, 2023 · Business

Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly 100,000 people in…

Read more Bluebird Bio Stock Is in Free Fall
Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers

Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers

December 19, 2023December 19, 2023 · Business

Dec 19, 2023, 4:31 am EST Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its all-time. The broad…

Read more Alphabet, Heico, Bluebird Bio, Plug Power, UBS, FedEx, and More Stock Market Movers
SmileDirectClub winds down operations — but customers are told to keep paying

SmileDirectClub winds down operations — but customers are told to keep paying

December 8, 2023December 8, 2023 · Breaking News

SmileDirectClub Inc. said late Friday it was winding down operations, effective immediately, seeming to cast its millions of customers adrift — except when it comes to their bills.…

Read more SmileDirectClub winds down operations — but customers are told to keep paying
GSK PLC 4Q Pre-items, Pretax Pft GBP1.56B

Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study

December 4, 2023December 4, 2023 · Breaking News

By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The Swiss pharmaceutical company said Tuesday…

Read more Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study
© 2026 . All rights reserved.